Article
Early behavioral deficits in R6/2 mice suitable for use in preclinical drug testing.
Neurobiology of disease - 1 Oct 2005
Hickey M A, Gallant K, Gross G G, Levine M S, Chesselet Marie-Françoise
Abstract excerpt
Huntington's disease (HD) is a neurodegenerative disorder caused by an elongated glutamine repeat in huntingtin. Improved understanding of the molecular effects of the mutation opens new avenues for treatment. High-throughput automated behavioral tests that produce well-defined markers of disease progression are necessary for in vivo drug screening. We have identified early behavioral deficits in tests of motor...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
